These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6753226)

  • 1. [Comparative beta-adrenoceptor blocking effects and pharmacokinetics of sotalol and propranolol in healthy volunteers].
    Richer C; Maury M; Poirier JM; Duhaze P; Giudicelli JF
    Therapie; 1982; 37(3):259-67. PubMed ID: 6753226
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
    Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
    Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative beta-adrenoceptor blocking effect and pharmacokinetics of bucindolol and propranolol in man.
    Maury M; Berdeaux A; Kher A; Duhaze P; Giudicelli JF
    Eur J Clin Pharmacol; 1985; 27(6):649-56. PubMed ID: 2859199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics in young normal and elderly hypertensive subjects: a study using sotalol as a model drug.
    Ishizaki T; Hirayama H; Tawara K; Nakaya H; Sato M; Sato K
    J Pharmacol Exp Ther; 1980 Jan; 212(1):173-81. PubMed ID: 6101341
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative antihypertensive effects and tissue distribution of beta adrenergic blocking drugs.
    Garvey HL; Ram N
    J Pharmacol Exp Ther; 1975 Jul; 194(1):220-33. PubMed ID: 1151751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism.
    Funck-Brentano C; Silberstein DJ; Roden DM; Wood AJ; Woosley RL
    Br J Clin Pharmacol; 1990 Aug; 30(2):195-202. PubMed ID: 2169833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma level and action of sotalol-HCL on the ECG interval after parenteral administration in healthy subjects].
    Rehm KD; Schnelle K; Dyde CJ; Blümner E; Arendts W
    Arzneimittelforschung; 1987 Sep; 37(9):1058-62. PubMed ID: 3435602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.
    Giudicelli JF; Chauvin M; Thuillez C; Richer C; Bianchetti G; Gomeni R; Morselli PL
    Br J Clin Pharmacol; 1980 Jul; 10(1):41-9. PubMed ID: 6104973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effect of sotalol and propranolol a double-blind crossover study.
    Berglund G
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):21-7. PubMed ID: 401708
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the cardiovascular effects of (+)-sotalol and (+/-)-sotalol following intravenous administration in normal volunteers.
    Johnston GD; Finch MB; McNeill JA; Shanks RG
    Br J Clin Pharmacol; 1985 Nov; 20(5):507-10. PubMed ID: 4074623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenoceptor blocking effects and plasma levels of bornaprolol and propranolol in man.
    Thuillez C; Richer C; Duhazé P; Bergougnan L; Giudicelli JF
    Eur J Clin Pharmacol; 1985; 29(4):405-11. PubMed ID: 3912184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetic and pharmacodynamic study of four different brands of propranolol in normal volunteers.
    Biswas NR; Garg SK; Kumar N; Mukherjee S; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):515-9. PubMed ID: 2583878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Alpha" and "beta" adrenergic receptors in the medullary vasomotor center of the cat.
    Share NN
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):362-73. PubMed ID: 4632860
    [No Abstract]   [Full Text] [Related]  

  • 17. A preliminary study on the interaction between ethanol and propranolol in normal human subjects.
    Chakrabarti A; Garg SK; Sharma PL
    Indian J Physiol Pharmacol; 1992 Jul; 36(3):209-12. PubMed ID: 1473855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol.
    Leahey WJ; Neill JD; Varma MP; Shanks RG
    Eur J Clin Pharmacol; 1980 Jun; 17(6):419-24. PubMed ID: 7398733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of labetalol and propranolol on responses to adrenaline infusion in healthy volunteers.
    Doshi BS; Kulkarni RD; Dattani KK; Anand MP
    Int J Clin Pharmacol Res; 1984; 4(1):29-33. PubMed ID: 6469431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sotalol and propranolol in mild to moderate essential hypertension.
    Pessina AC; Hlede M; Morandin F; Casiglia E; Gava R; Agnoletto V; Locatelli C; Dal Palu C
    Int J Clin Pharmacol Res; 1983; 3(1):41-5. PubMed ID: 6679506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.